Inotiv Inc
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DMS segment manufactures scientific instruments for life sciences researc… Read more
Inotiv Inc (NOTV) - Total Liabilities
Latest total liabilities as of December 2025: $625.31 Million USD
Based on the latest financial reports, Inotiv Inc (NOTV) has total liabilities worth $625.31 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Inotiv Inc - Total Liabilities Trend (1997–2025)
This chart illustrates how Inotiv Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Inotiv Inc Competitors by Total Liabilities
The table below lists competitors of Inotiv Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zakłady Lentex SA
WAR:LTX
|
Poland | zł93.79 Million |
|
GNCO Co. Ltd
KQ:065060
|
Korea | ₩122.63 Billion |
|
Sub Sri Thai Real Estate Investment Trust
BK:SSTRT
|
Thailand | ฿144.41 Million |
|
Tander Inversiones SOCIMI SA
MC:YTAN
|
Spain | €110.84 Million |
|
Oriental Carbon & Chemicals Limited
NSE:OCCL
|
India | ₹310.72 Million |
Liability Composition Analysis (1997–2025)
This chart breaks down Inotiv Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inotiv Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inotiv Inc (1997–2025)
The table below shows the annual total liabilities of Inotiv Inc from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $635.09 Million | +3.97% |
| 2024-09-30 | $610.86 Million | +3.88% |
| 2023-09-30 | $588.04 Million | -2.50% |
| 2022-09-30 | $603.13 Million | +178.29% |
| 2021-09-30 | $216.73 Million | +301.37% |
| 2020-09-30 | $54.00 Million | +72.68% |
| 2019-09-30 | $31.27 Million | +53.40% |
| 2018-09-30 | $20.38 Million | +70.58% |
| 2017-09-30 | $11.95 Million | -12.65% |
| 2016-09-30 | $13.68 Million | +4.46% |
| 2015-09-30 | $13.10 Million | -8.01% |
| 2014-09-30 | $14.24 Million | -11.77% |
| 2013-09-30 | $16.14 Million | -7.17% |
| 2012-09-30 | $17.39 Million | +3.73% |
| 2011-09-30 | $16.76 Million | -12.14% |
| 2010-09-30 | $19.08 Million | -2.00% |
| 2009-09-30 | $19.46 Million | -13.69% |
| 2008-09-30 | $22.55 Million | -3.96% |
| 2007-09-30 | $23.48 Million | -5.92% |
| 2006-09-30 | $24.96 Million | -11.62% |
| 2005-09-30 | $28.24 Million | +3.16% |
| 2004-09-30 | $27.38 Million | +8.38% |
| 2003-09-30 | $25.26 Million | +73.43% |
| 2002-09-30 | $14.56 Million | +43.54% |
| 2001-09-30 | $10.15 Million | -4.29% |
| 2000-09-30 | $10.60 Million | +19.11% |
| 1999-09-30 | $8.90 Million | +61.82% |
| 1998-09-30 | $5.50 Million | -38.89% |
| 1997-09-30 | $9.00 Million | -- |